Female Sexual Dysfunction

Female Sexual Dysfunction refers to difficulties with sexual function, framed here within a hormonal health context. A person may notice changes involving sexual desire, arousal, vaginal lubrication, orgasmic response, or sexual fulfillment.

Understand how Female Sexual Dysfunction is framed within a hormonal health context.

3What may help

This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.

What may help

None of these options has good evidence yet. Best evidence first.

3 options:3 not enough evidence

What studies foundSize of effect

BreathworkpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
Open the Breathwork page
PilatespracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A 2025 non-randomized study of 93 women with an FSFI total score ≤ 26.55 and no sexual annoyance found improvements in FSFI, ASEX and BDI scores versus controls.
Open the Pilates page
MeditationpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
Open the Meditation page

The expert view shows every study, dose protocol and source.

What may help

Interventions recorded as helping with this condition3 listed

The best we have, but the evidence is still weak

PracticesBreathworkCertaintyLowSourceClinical
A trial in 64 participants found the FSFI total score increased by MD 5.01 (95% CI 3.21 to 6.79, p=0.001), exceeding the FSFI MCID (4.2); 23.33% reached FSFI >28.1 versus 0% in control.
Who was studied
People with a condition
Study result
RCT: FSFI total score increase MD 5.01 (95% CI 3.21 to 6.79, p=0.001), Cohen's d=1.43, exceeding the FSFI MCID (4.2); 23.33% reached FSFI >28.1 vs 0% in control.
Open Breathwork
→
PracticesPilatesCertaintyLowSourceClinical
A 2025 non-randomized study of 93 women with an FSFI total score ≤ 26.55 and no sexual annoyance found improvements in FSFI, ASEX and BDI scores versus controls.
Who was studied
People with a condition
Study result
Women with FSFI total score ≤ 26.55 and no sexual annoyance were enrolled; Pilates improved FSFI, ASEX and BDI scores in this group versus controls in a non-randomized design.
Open Pilates
→
PracticesMeditationCertaintyLowSourceReview
Direct randomized controlled trials and small-to-moderate meta-analytic effects summarised in Table 1; mindfulness-based interventions improved desire and reduced distress.
Who was studied
People with a condition
Open Meditation
→

What to avoid

Interventions recorded as making it worse

Nothing in this library is currently recorded as making Female Sexual Dysfunction worse. Coverage is partial, and absence here is not evidence of safety.

Browse the supplements that are written up

How to read the evidence

Evidence tier — overall strength of the evidence for the whole compound

StrongWell established — backed by strong, consistent human research.
ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
LimitedVery limited evidence — treat this as a hypothesis, not proof.
InsufficientNot enough good evidence to draw conclusions yet.

Certainty — how sure we can be that the effect is real

Very highVery sure — strong, consistent evidence
HighFairly sure — consistent evidence from good studies
MediumModerately sure — new studies could change this
LowNot sure — little or mixed evidence
Very lowVery unsure — almost no usable evidence

Source — where the data comes from

Meta-analysisPooled analysis of many trials — the strongest evidence
RCTRandomized controlled trial — a strong human study design
ClinicalA human clinical study
Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
Animal researchStudied in animals, not humans
Community reportsAggregated user reports — anecdotal signal, not evidence
TheoreticalMechanism-based reasoning, not yet tested

Study grade — quality of each underlying study (A best, D weakest)

AHigh-quality — strong, consistent human trials
BGood — solid evidence with some limitations
CModerate — limited, small, or mixed-quality studies
DWeak — preliminary, indirect, or animal-only

Confidence — how strongly the sources back a finding

A 0–100 score from study quality and agreement

Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.

Full write-up

What is it

It is not limited to low desire alone: desire-related concerns such as HSDD are one possible presentation, while sexual dysfunction may also involve other aspects of sexual response. The examples discussed include Ashwagandha, Saffron Extract, Tribulus Terrestris, and Vitamin E.

Evidence-backed options

The options associated with Female Sexual Dysfunction have been studied in different ways, so their findings are not interchangeable. Ashwagandha was taken daily at 600 mg for eight weeks. Compared with placebo, this was associated with better sexual function across arousal, vaginal lubrication, orgasmic response, and sexual fulfillment. The available finding describes outcomes after the eight-week period; it does not establish how quickly changes appeared during treatment or whether they persisted afterward.

Saffron Extract and Vitamin E were evaluated as a combination rather than as equivalent standalone options. The combination was more effective than Vitamin E alone for improving sexual function and its domains in women of reproductive age with sexual dysfunction without severe depression. The information provided does not specify the doses, treatment duration, or timing of any changes for this comparison, so those details cannot be used to compare it directly with the Ashwagandha study.

Tribulus Terrestris was associated with possible improvement in desire in women with HSDD, but the available finding does not specify a dose, treatment duration, or onset of effect. Overall, the findings address different aspects of sexual function, including desire and broader sexual-function domains, and the studied populations and treatment details are not uniform. These options are educational reference points rather than treatment instructions; a clinician can help interpret their relevance to an individual medical condition.